Interestingly, this was the only hypertension medication that is correlated with higher IL-6 levels, and neither angiotensin-converting-enzyme (ACE)-inhibitors (ATC: C09AA), selective β-blocker agents (ATC: C07AB) nor a combination of these mediate this effect (Fig. 3f). This evidence concerns the gene ACE and hypertensive disorder.